We found that OCT1 levels were elevated for higher (more aggressive) T stages of ESCC (ie, Stage III or IV) compared to lower T stages (ie, Stage I or II) (Figure 5A). This evidence concerns the gene POU2F1 and esophageal squamous cell carcinoma.